Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

ValiRx (VAL) Share News

ValiRx Notes Encouraging Performance Of VAL201 In Cancer Trial

21st Mar 2019 09:53

LONDON (Alliance News) - ValiRx PLC on Thursday said an interim inspection of its VAL201 early phase cancer trial shows the drug is performing as predicted.Shares in ValiRx were up 13% at a Read More

ValiRx Raises GBP500,000 Through Placing To Advance Clinical Trials (ALLISS)

21st Feb 2019 12:46

LONDON (Alliance News) - ValiRx PLC on Thursday raised GBP500,000 through a share placing to expand its clinical trial of VAL201, as well as the VAL301 and VAL101 programmes.ValiRx issued a Read More

ValiRx Secures Patent For VAL301 Compound In Russia And China

31st Jan 2019 13:37

LONDON (Alliance News) - ValiRx PLC on Thursday said it has been granted a patent allowance for its therapeutic compound VAL301 in both Russia and China.The clinical stage biotechnology has Read More

ValiRx Backs New Long-Term UK Government Plan For NHS

9th Jan 2019 11:25

LONDON (Alliance News) - Biotechnology firm ValiRx PLC on Wednesday said it endorses the UK government's new NHS long-term plan."The government's recently announced ten-year a Read More

WINNERS & LOSERS SUMMARY: Just Group Jumps 23% On Regulatory Decision

10th Dec 2018 10:59

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------NMC up The Read More

ValiRx Reports Positive VAL201 Effect On Patients With Prostate Cancer

10th Dec 2018 09:06

LONDON (Alliance News) - ValiRx PLC on Monday said an independent analysis of VAL201 showed a positive effect on patients with hormone-sensitive and hormone-resistant prostate cancer.The up Read More

ValiRx Half Year Loss Widens On Expenses And Share Option Charge

25th Sep 2018 13:23

LONDON (Alliance News) - Life science company ValiRx PLC on Tuesday reported a widened loss in the first half of 2018 due to expenses and a sizeable share option charge.The company's to Read More

ValiRx Says Clinical Study For Lung Cancer Drug VAL401 Is Approved

6th Sep 2018 11:38

LONDON (Alliance News) - Clinical stage biotechnology company ValiRx PLC said Thursday its clinical study report on lung cancer drug VAL401 has been signed and approved by principal in ValiRx were Read More

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

14th Jun 2018 11:00

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2.6%. The jet engine maker said it will cut Read More

Nicholas Slater Increases ValiRx Stake To 4.5% From 2.7% (ALLISS)

11th May 2018 16:43

LONDON (Alliance News) - ValiRx PLC said Friday Nicholas Slater had almost doubled his stake in life science company, which focuses on cancer treatments, to 4.5% after a transaction on raised his Read More

ValiRx Raises GBP950,000 Through Placing To Progress Pipeline (ALLISS)

4th May 2018 17:08

LONDON (Alliance News) - ValiRx PLC said Friday it has raised GBP950,000 through the issue of 47.5 million shares at 2.00 pence per share.The clinical stage biotechnology company's down Read More

"Major" Milestone As ValiRx's VAL201 Is Granted Patent In EU

25th Apr 2018 13:41

LONDON (Alliance News) - Biotechnology company ValiRx PLC said Wednesday its VAL201 compound has been granted a patent in the EU.This, it said, follows a US patent which was granted for a a Read More

ValiRx Posts Positive Results From VAL101 Compound Pre-Clinical Trials

19th Apr 2018 12:41

LONDON (Alliance News) - ValiRx PLC on Thursday said pre-clinical studies showed that its VAL101 compund has a potential to prevent cancer growth at cellular biochemical and genomic molecule is is Read More

ValirX Gets US Patent For Proposed VAL201 Cancer Treatment

20th Mar 2018 13:55

LONDON (Alliance News) - Biotechnology firm ValirX PLC said Tuesday its VAL201 therapeutic compound has been granted a patent in the US.VAL201, which is currently in is Read More

YA II CD Lowers ValiRx Interest To Below 3% Threshold (ALLISS)

19th Mar 2018 12:46

LONDON (Alliance News) - Life sciences firm ValiRx PLC said on Monday YA II CD Ltd has cut its stake in the company to below 3%.Prior to last Thursday's YA II CD a Read More

ValiRx To Expand VAL201 Studies After Positive Results

11th Jan 2017 09:01

ValiRx Interim Loss Widens As It Progresses Drug Pipeline

27th Sep 2016 10:17

ValiRx Gets Patent Coverage For VAL401 In New Zealand

28th Jul 2016 08:41

ValiRx Issues Shares To Bracknor For Loan Note Conversion (ALLISS)

26th Jul 2016 09:43

ValiRx Receives Approval To Submit Application For Cancer Drug Trial

14th Jul 2016 08:50

FTSE 100 Latest

Value10,223.54

Change51.78